日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Retinal progenitor cells (jCell) for retinitis pigmentosa

用于治疗视网膜色素变性的视网膜祖细胞（jCell）

期刊:Frontiers in Cellular Neuroscience
影响因子:4
doi:10.3389/fncel.2025.1646156
Yang, Jing; Kuppermann, Baruch D; Liao, David; Mehta, Mitul C; Hsiang, Chinhui; Menges, Steven; Boyer, David S; Klassen, Henry
细胞生物学
发表日期：2025
文献求助 收藏

A pan-beta-coronavirus vaccine bearing conserved and asymptomatic B- and T-cell epitopes protects against highly pathogenic Delta and highly transmissible Omicron SARS-CoV-2 variants.

一种含有保守且无症状的 B 细胞和 T 细胞表位的泛 β 冠状病毒疫苗可预防高致病性 Delta 和高传染性 Omicron SARS-CoV-2 变种

期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2025.2527438
Vahed Hawa, Prakash Swayam, Quadiri Afshana, Ibraim Izabela Coimbra, Omorogieva Etinosa, Patel Swena, Tadros Jimmy, Liao Emma Jane, Lau Lauren, Chentoufi Aziz A, Nesburn Anthony B, Kuppermann Baruch D, Ulmer Jeffrey B, Gil Daniel, BenMohamed Lbachir
细胞生物学
新冠
发表日期：2025
文献求助 收藏

Biosimilar Ranibizumab (Ranieyes) Safety and Efficacy in the Real World: BRESER Study

生物类似药雷珠单抗（Ranieyes）在真实世界中的安全性和有效性：BRESER 研究

期刊:Journal of VitreoRetinal Diseases
影响因子:0.8
doi:10.1177/24741264251322213
Sharma, Ashish; Holz, Frank G; Kumar, Nilesh; Sarraf, David; Ayachit, Seemantini; Mishra, Chitaranjan; Tufail, Adnan; Chakraborty, Debdulal; Rachitskaya, Aleksandra; Eichenbaum, David; Banker, Alay; Parachuri, Nikulaa; Kumar, Ashish; Loewenstein, Anat; Bandello, Francesco; Wakabayashi, Taku; Woo, Se Joon; Kuppermann, Baruch D
发表日期：2025
文献求助 收藏

Secondary Macular Hole Closure With Sub-Tenon Triamcinolone Acetonide

继发性黄斑裂孔用球后注射曲安奈德治疗

期刊:Journal of VitreoRetinal Diseases
影响因子:0.8
doi:10.1177/24741264251364009
Azimi, Reza; Hassan, Amr K; Ghafari, Elina; Kuppermann, Baruch D; Mehta, Mitul C
发表日期：2025
文献求助 收藏

Aflibercept 2 mg biosimilars-will they lead the Anti-VEGF biosimilar world globally

阿柏西普 2 毫克生物类似药——它们能否在全球抗 VEGF 生物类似药领域引领潮流？

期刊:
影响因子:
doi:10.1038/s41433-025-03732-2
Sharma, Ashish; Woo, Se Joon; Lee, Christopher Seungkyu; Kumar, Nilesh; Parachuri, Nikulaa; Bandello, Francesco; Loewenstein, Anat; Kuppermann, Baruch D
VEGF
EGF
发表日期：2025
文献求助 收藏

Cross-protection induced by highly conserved human B, CD4(+), and CD8(+) T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern

基于高度保守的人类B细胞、CD4(+)和CD8(+)T细胞表位的疫苗可诱导交叉保护，预防多种SARS-CoV-2变异株引起的严重感染、疾病和死亡。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1328905
Prakash, Swayam; Dhanushkodi, Nisha R; Zayou, Latifa; Ibraim, Izabela Coimbra; Quadiri, Afshana; Coulon, Pierre Gregoire; Tifrea, Delia F; Suzer, Berfin; Shaik, Amin Mohammed; Chilukuri, Amruth; Edwards, Robert A; Singer, Mahmoud; Vahed, Hawa; Nesburn, Anthony B; Kuppermann, Baruch D; Ulmer, Jeffrey B; Gil, Daniel; Jones, Trevor M; BenMohamed, Lbachir
T细胞
T细胞
SARS-CoV-2
CD4
CD8
免疫/内分泌
B细胞
细胞生物学
炎症/感染
发表日期：2024
文献求助 收藏

High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4+ and CD8+ memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients

在未接种疫苗的 COVID-19 患者中，高频率的 α 普通感冒冠状病毒/SARS-CoV-2 交叉反应功能性 CD4+ 和 CD8+ 记忆 T 细胞与预防有症状和致命的 SARS-CoV-2 感染有关

期刊:Frontiers in Immunology
影响因子:5.7
doi:10.3389/fimmu.2024.1343716
Pierre-Gregoire Coulon #, Swayam Prakash #, Nisha R Dhanushkodi, Ruchi Srivastava, Latifa Zayou, Delia F Tifrea, Robert A Edwards, Cesar J Figueroa, Sebastian D Schubl, Lanny Hsieh, Anthony B Nesburn, Baruch D Kuppermann, Elmostafa Bahraoui, Hawa Vahed, Daniel Gil, Trevor M Jones, Jeffrey B Ulmer, L
免疫
细胞生物学
新冠
其它细胞
发表日期：2024
文献求助 收藏

Extended Intraocular Drug-Delivery Platforms for the Treatment of Retinal and Choroidal Diseases

用于治疗视网膜和脉络膜疾病的扩展型眼内药物输送平台

期刊:Journal of VitreoRetinal Diseases
影响因子:0.8
doi:10.1177/24741264241267065
Wykoff, Charles C; Kuppermann, Baruch D; Regillo, Carl D; Chang, Margaret; Hariprasad, Seenu M; Duker, Jay S; Altaf, Syed; Saïm, Saïd
发表日期：2024
文献求助 收藏

Aflibercept biosimilars - update on the development progress

阿柏西普生物类似药——研发进展最新情况

期刊:
影响因子:
doi:10.1038/s41433-023-02813-4
Sharma, Ashish; Loewenstein, Anat; Kumar, Nilesh; Parachuri, Nikulaa; Bandello, Francesco; Kuppermann, Baruch D
发表日期：2024
文献求助 收藏

Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI)

由国际视网膜生物类似药研究组（Inter-BIOS Group）与印度玻璃体视网膜学会（VRSI）合作开展的《2023 年印度抗 VEGF 视网膜疾病生物类似药调查》（Bio-INDAS）

期刊:
影响因子:
doi:10.1038/s41433-024-03284-x
Sharma, Ashish; Kaiser, Peter K; Tadayoni, Ramin; Holz, Frank G; Nicholson, Luke; Vazquez-Alfageme, Clara; Sivaprasad, Sobha; Wakabayashi, Taku; Woo, Se Joon; Sarraf, David; Kumar, Nilesh; Parachuri, Nikulaa; Regillo, Carl D; Rezaei, Kourous A; Khanani, Arshad M; Bandello, Francesco; Shanamugam, Mahesh; Verma, Lalit; Dogra, Mangat Ram; Ns, Muralidhar; Agarwal, Manisha; Loewenstein, Anat; Kuppermann, Baruch D
VEGF
EGF
发表日期：2024
文献求助 收藏